Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.
BACKGROUND
A severe adverse reaction to sulfasalazine therapy has been associated with hypersensitivity syndrome, the clinical features of which are similar to infectious mononucleosis. No serologic evidence of viral infections has been reported with this syndrome; however, human herpesvirus 6 infection has not been specifically investigated, which could cause an infectious mononucleosislike syndrome.


METHODS
We report 2 cases of hypersensitivity syndrome induced by the use of sulfasalazine. The clinical features of the syndrome appeared 18 and 32 days after administration of sulfasalazine. Clinical signs included a maculopapular rash progressing to exfoliate erythroderma, fever, and lymphadenopathy. Leukocytosis, atypical lymphocytes, liver dysfunction, and renal disturbance were also observed. In 1 patient, human herpesvirus 6 variant B was isolated from peripheral blood mononuclear cells, and in both patients anti-human herpesvirus 6 IgG titers increased considerably.


CONCLUSIONS
Two cases of hypersensitivity syndrome due to sulfasalazine use were associated with the reactivation of human herpesvirus 6, which may be a required cause of hypersensitivity syndrome.
Department of Dermatology, Ehime University School of Medicine, Japan. tohm@m.ehime-u.ac.jp
M
M
Tohyama
Y
Y
Yahata
M
M
Yasukawa
R
R
Inagi
Y
Y
Urano
K
K
Yamanishi
K
K
Hashimoto
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000821:virology*; D005260:Female; D006566:Herpesviridae Infections / Q000150:complications*; D015654:Herpesvirus 6, Human; D006801:Humans; D008297:Male; D012720:Severity of Illness Index; D012460:Sulfasalazine / Q000009:adverse effects*; D013577:Syndrome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine